Bounded answer
Preserve uncertainty across biomolecular claims and Evidence Dossiers by carrying the originating interval or distribution, dependence assumptions, transformations, and validity boundary. Never replace unknown uncertainty with zero.
This guide defines a possible bridge contract. It does not assert that evidence, quantities, mechanisms, or validity transfer between the named domains.
Input contract
What must be fixed first
Exact records and active revisions on both sides
Declared bridge type and terminology map
Source, locator, rights, and claim scope for each side
Transfer rule for units, uncertainty, and prohibited inference
Procedure
Work the decision in order
- 1
Define both sides of biomolecular claims and Evidence Dossiers in their own vocabularies.
- 2
Verify each source and revision independently.
- 3
Classify the bridge as exact, mechanistic, statistical, instrumental, analogical, or strategic.
- 4
Test whether quantities, assumptions, and uncertainty may transfer.
- 5
Refuse every unlicensed inference and preserve disagreement.
- 6
Emit a digest-bound bridge record and retrieval contract.
Expected outputs
- Typed cross-domain bridge
- Two-sided source and revision map
- Transfer and non-transfer rules
Refuse when
- Either side lacks inspected, exact-revision evidence.
- A metaphor or shared term is treated as a mechanism.
- Units, assumptions, scope, or uncertainty are dropped at the bridge.
Subject-specific decision record
What a complete answer would require
- Minimum evidence
- Exact records and active revisions on both sides; Declared bridge type and terminology map; Source, locator, rights, and claim scope for each side; Transfer rule for units, uncertainty, and prohibited inference.
- Pass condition
- Return typed cross-domain bridge, two-sided source and revision map, transfer and non-transfer rules only after every required input and ordered check is satisfied.
- Current result
- No subject-specific result has been produced by this method guide.
Questions this guide answers
How must uncertainty be preserved between biomolecular claims and Evidence Dossiers?
Preserve uncertainty across biomolecular claims and Evidence Dossiers by carrying the originating interval or distribution, dependence assumptions, transformations, and validity boundary. Never replace unknown uncertainty with zero.
What inputs must be fixed for biomolecular claims and Evidence Dossiers?
Exact records and active revisions on both sides; Declared bridge type and terminology map; Source, locator, rights, and claim scope for each side; Transfer rule for units, uncertainty, and prohibited inference.
What should a machine return for biomolecular claims and Evidence Dossiers?
Typed cross-domain bridge; Two-sided source and revision map; Transfer and non-transfer rules. Every output remains bound to the exact inputs and decision state.
When must a system refuse biomolecular claims and Evidence Dossiers?
Either side lacks inspected, exact-revision evidence. A metaphor or shared term is treated as a mechanism. Units, assumptions, scope, or uncertainty are dropped at the bridge.
What does this guide not establish about biomolecular claims and Evidence Dossiers?
A bridge organizes relationships and does not raise either side’s evidence maturity. Analogical and strategic links transfer no scientific validity. Machine retrieval requires its own entitlement and exact selectors.
Limits
- A bridge organizes relationships and does not raise either side’s evidence maturity.
- Analogical and strategic links transfer no scientific validity.
- Machine retrieval requires its own entitlement and exact selectors.